JP2023515190A5 - - Google Patents
Info
- Publication number
- JP2023515190A5 JP2023515190A5 JP2022551573A JP2022551573A JP2023515190A5 JP 2023515190 A5 JP2023515190 A5 JP 2023515190A5 JP 2022551573 A JP2022551573 A JP 2022551573A JP 2022551573 A JP2022551573 A JP 2022551573A JP 2023515190 A5 JP2023515190 A5 JP 2023515190A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062982561P | 2020-02-27 | 2020-02-27 | |
| US62/982,561 | 2020-02-27 | ||
| PCT/US2021/019989 WO2021174058A1 (en) | 2020-02-27 | 2021-02-26 | Methods and compositions for treatment of apc-deficient cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023515190A JP2023515190A (ja) | 2023-04-12 |
| JP2023515190A5 true JP2023515190A5 (https=) | 2024-02-27 |
| JPWO2021174058A5 JPWO2021174058A5 (https=) | 2024-02-27 |
Family
ID=77490376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551573A Pending JP2023515190A (ja) | 2020-02-27 | 2021-02-26 | Ａｐｃ欠損がんの治療のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230250433A1 (https=) |
| EP (1) | EP4110923A4 (https=) |
| JP (1) | JP2023515190A (https=) |
| KR (1) | KR20230004458A (https=) |
| CN (1) | CN115515636A (https=) |
| AU (1) | AU2021226012A1 (https=) |
| BR (1) | BR112022016903A2 (https=) |
| CA (1) | CA3172886A1 (https=) |
| MX (1) | MX2022010644A (https=) |
| WO (1) | WO2021174058A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025160462A1 (en) * | 2024-01-24 | 2025-07-31 | Iterion Therapeutics Inc. | Methods for treatment of hepatocellular carcinoma |
| CN119236084A (zh) * | 2024-11-06 | 2025-01-03 | 上海市皮肤病医院 | 一种tdo2抑制剂在制备治疗皮肤鳞状细胞癌药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110159017A1 (en) * | 2008-04-11 | 2011-06-30 | Ludwig Institute For Cancer Research Ltd. | Trytophan catabolism in cancer treatment and diagnosis |
| EP3334733A1 (en) * | 2015-08-10 | 2018-06-20 | Pfizer Inc | 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| CN107021929A (zh) * | 2016-01-29 | 2017-08-08 | 苏州国匡医药科技有限公司 | 一类新型ido抑制剂、制备方法、药物组合物及其用途 |
| CN110791565B (zh) * | 2019-09-29 | 2021-09-03 | 浙江大学 | 一种用于ii期结直肠癌复发预测的预后标记基因及随机生存森林模型 |
-
2021
- 2021-02-26 WO PCT/US2021/019989 patent/WO2021174058A1/en not_active Ceased
- 2021-02-26 MX MX2022010644A patent/MX2022010644A/es unknown
- 2021-02-26 AU AU2021226012A patent/AU2021226012A1/en active Pending
- 2021-02-26 KR KR1020227033055A patent/KR20230004458A/ko active Pending
- 2021-02-26 US US17/905,124 patent/US20230250433A1/en active Pending
- 2021-02-26 EP EP21761503.8A patent/EP4110923A4/en active Pending
- 2021-02-26 JP JP2022551573A patent/JP2023515190A/ja active Pending
- 2021-02-26 BR BR112022016903A patent/BR112022016903A2/pt unknown
- 2021-02-26 CN CN202180030841.5A patent/CN115515636A/zh active Pending
- 2021-02-26 CA CA3172886A patent/CA3172886A1/en active Pending